We are live on
!
Find out more
E Fund Management Portfolio holdings
AUM
$4.46B
Turnover
13.19%
This Fund
S&P 500
This Quarter
Est. Return
+29.65%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.58B
AUM Growth
+$264M
(+20%)
Cap. Flow
-$56.9M
Cap. Flow
% of AUM
-3.61%
Top 10 Holdings %
Top 10 Hldgs %
70.28%
Holding
330
New
38
Increased
107
Reduced
155
Closed
24
Avg Time Held
1.8
years
Top 10 Avg Time Held
0.8
years
Top 20 Avg Time Held
1.4
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JOYY Inc
JOYY
|
+$3.5M |
| 2 |
Weibo
WB
|
+$2.7M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$1.76M |
| 4 |
Hesai Group
HSAI
|
+$1.67M |
| 5 |
Structure Therapeutics
GPCR
|
+$1.64M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
STAAR Surgical
STAA
|
+$23.4M |
| 2 |
Yum China
YUMC
|
+$14M |
| 3 |
TSMC
TSM
|
+$8.84M |
| 4 |
Pinduoduo
PDD
|
+$8.79M |
| 5 |
Apple
AAPL
|
+$4.77M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 50.26% |
| 2 | Technology | 23.48% |
| 3 | Communication Services | 8.85% |
| 4 | Real Estate | 5.2% |
| 5 | Healthcare | 4.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
101
Eli Lilly
LLY
$1.13T
| $881K | 0.06% |
1,512
+117
| +8% | +$68.3K |
2021 Q1
11 quarters
|
|
102
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$29.4B
| $874K | 0.06% |
7,900
| – | – |
2022 Q2
6 quarters
|
|
103
Microchip Technology
MCHP
$40.9B
| $832K | 0.05% |
9,224
-869
| -9% | -$70.8K |
2021 Q1
11 quarters
|
|
104
JPMorgan Chase
JPM
$909B
| $777K | 0.05% |
4,569
+33
| +0.7% | +$5K |
2021 Q1
11 quarters
|
|
105
Johnson & Johnson
JNJ
$618B
| $746K | 0.05% |
4,760
+452
| +10% | +$69.3K |
2021 Q1
11 quarters
|
|
106
Visa
V
$757B
| $742K | 0.05% |
2,849
+127
| +5% | +$31.3K |
2021 Q1
11 quarters
|
|
107
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $740K | 0.05% |
2,338
-144
| -6% | -$28K |
2022 Q1
7 quarters
|
|
108
Incyte
INCY
$23.2B
| $735K | 0.05% |
11,712
+2,886
| +33% | +$163K |
2021 Q1
11 quarters
|
|
109
Mercado Libre
MELI
$93.5B
| $732K | 0.05% |
466
-35
| -7% | -$49.6K |
2021 Q1
11 quarters
|
|
110
Acadia Pharmaceuticals
ACAD
$3.34B
| $717K | 0.05% |
22,893
+5,605
| +32% | +$134K |
2022 Q1
7 quarters
|
|
111
RLX Technology
RLX
$2.11B
| $705K | 0.04% |
+352,589
| New | +$656K |
2023 Q4
0 quarters
|
|
112
Idexx Laboratories
IDXX
$44B
| $702K | 0.04% |
1,264
+101
| +9% | +$47.4K |
2021 Q1
11 quarters
|
|
113
Fortinet
FTNT
$129B
| $699K | 0.04% |
11,949
-1,366
| -10% | -$75.5K |
2021 Q1
11 quarters
|
|
114
CSX Corp
CSX
$90.6B
| $682K | 0.04% |
19,675
-2,384
| -11% | -$75.9K |
2021 Q1
11 quarters
|
|
115
Datadog
DDOG
$91.4B
| $681K | 0.04% |
5,609
-221
| -4% | -$22.8K |
2023 Q2
2 quarters
|
|
116
PayPal
PYPL
$49.1B
| $659K | 0.04% |
10,735
-1,337
| -11% | -$76.6K |
2021 Q1
11 quarters
|
|
117
Cognizant
CTSH
$29.4B
| $643K | 0.04% |
8,516
-848
| -9% | -$58.5K |
2021 Q1
11 quarters
|
|
118
Mastercard
MA
$543B
| $640K | 0.04% |
1,501
+74
| +5% | +$29.7K |
2021 Q1
11 quarters
|
|
119
Alnylam Pharmaceuticals
ALNY
$31.7B
| $639K | 0.04% |
3,340
+1,069
| +47% | +$182K |
2022 Q1
7 quarters
|
|
120
ExxonMobil
XOM
$723B
| $634K | 0.04% |
6,338
+90
| +1% | +$9.46K |
2021 Q1
11 quarters
|
|
121
DexCom
DXCM
$33.2B
| $632K | 0.04% |
5,093
-22
| -0.4% | -$2.25K |
2021 Q1
11 quarters
|
|
122
Biohaven
BHVN
$1.68B
| $622K | 0.04% |
14,528
-3,080
| -17% | -$95.8K |
2022 Q3
5 quarters
|
|
123
ON Semiconductor
ON
$28.7B
| $611K | 0.04% |
7,316
-4,193
| -36% | -$329K |
2022 Q2
6 quarters
|
|
124
DELISTED
Amicus Therapeutics
FOLD
| $604K | 0.04% |
42,548
+6,171
| +17% | +$70.1K |
2021 Q1
11 quarters
|
|
125
Cintas
CTAS
$85B
| $603K | 0.04% |
4,000
-380
| -9% | -$50.9K |
2021 Q1
11 quarters
|
|
Similar funds
E Fund Management's Q4 2023 Portfolio in Review
As of Q4 2023, E Fund Management held 330 positions worth $1.58B, up 20% from $1.31B the previous quarter. Its ten largest holdings account for 70% of the portfolio.
E Fund Management withdrew a net $56.9M in Q4 2023, closing 24 positions and reducing 155 holdings. Its most notable exit was MINISO, an estimated $2.17M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 50% of assets, up from 45% a quarter earlier, followed by Technology and Communication Services.
Against the trend, E Fund Management opened a new position in Hesai Group worth $1.52M.
- E Fund Management's largest Q4 2023 buy was Hesai Group: 170,914 shares worth $1.52M.
- E Fund Management added most to JOYY Inc in Q4 2023, an estimated $3.5M increase.
- E Fund Management's biggest Q4 2023 reduction was STAAR Surgical, cutting an estimated $23.4M.
- E Fund Management fully exited MINISO in Q4 2023, selling an estimated $2.17M.
- E Fund Management's ten largest holdings make up 70% of its $1.58B portfolio in Q4 2023.
- E Fund Management opened 38 new positions and closed 24 in Q4 2023.
- E Fund Management's portfolio value rose 20% quarter-over-quarter to $1.58B.
Based on E Fund Management's 13F filing for Q4 2023, filed 7 Feb 2024.